IFRS in the Life Sciences: Broad implications

IFRS in the Life Sciences: Broad implications

Analyze the companies that are moving assertively toward International Financial Reporting Standards (IFRS), and you’ll note several predominant characteristics. Most have global operations, complex organizational structures, and aggressive competition. They are often publicly held. And they frequently are known for innovation and leadership. In other words, they sound a lot like a global life sciences company. This publication "IFRS in the Life Sciences: Broad Implications" provides practical industry insights on IFRS for life science executives and includes useful sections on: IFRS challenges and opportunities in life sciences; Implications of IFRS for financial reporting, tax, human resources, mergers and acquisitions, IT, and treasury; Key actions steps for life science executives; Approaches to IFRS conversion; Key differences between IFRS and U.S. Generally Accepted Accounting Principles (GAAP) for the life science industry.
04 Sep 2009
03 Sep 2009
15 Page(s)
White Paper
Already a Bitpipe member? Login here

Download this White Paper!

By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.

You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.

Safe Harbor